10 free leads on us
Vectura Group
Headquarters
London, Greater London Office
London, Greater London Office
Vectura is a provider of innovative inhaled drug delivery solutions that enable partners to bring their medicines to patients. With differentiated proprietary technology and pharmaceutical development expertise, Vectura is one of the few companies globally with the device, formulation and development capabilities to deliver a broad range of complex inhaled therapies. Vectura has eleven key inhal ed and eleven non-inhaled products marketed by partners with global royalty streams, and a diverse partnered portfolio of drugs in clinical development. Our partners include Hikma, Novartis, Sandoz (a division of Novartis AG), Mundipharma, Kyorin, GSK, Bayer, Chiesi, Almirall, and Tianjin KingYork.
...Read MoreVECTURA GROUP PLC
Vectura
Vectura Limited
Vectura Group
Vectura Group Ltd
$209.2 M
510
1997
Vectura Group raised a total of $24.3 M in funding over 1 rounds, and is a public traded company.
LON: VEC
Name & Title | Social | Contact Info | |
---|---|---|---|
Ekaterina Golubeva Deputy Sales Director | Visit Profile |
Name & Title | Social | Contact Info | |
---|---|---|---|
Andriy Lazarenko Self Employed | Visit Profile | ||
Vijaya Krishna Vectura | Visit Profile | ||
Tony Gilani Quality Assurance Lead | Visit Profile | ||
Ekaterina Golubeva Deputy Sales Director | Visit Profile |
Here's a list of some of the top trending technologies and APIs used by Vectura Group.
(3 Technologies)
(2 Technologies)
(2 Technologies)
(2 Technologies)
(2 Technologies)
Company | Employees | Revenue | Top technologies |
---|---|---|---|
Intarcia Therapeutics | 275 | $53.8 M | |
Nektar Therapeutics | 618 | $1.2 B | |
MannKind | 232 | $63 M | |
Ethypharm | 1,400 | $347.9 M | |
Alkermes | 2,235 | $1.2 B |